Log in

Relevant bibliographies by topics / Cellules de Langerhans (CL) / Journal articles

To see the other types of publications on this topic, follow the link: Cellules de Langerhans (CL).

Journal articles on the topic 'Cellules de Langerhans (CL)'

Author: Grafiati

Published: 31 May 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 38 journal articles for your research on the topic 'Cellules de Langerhans (CL).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Valladeau, Jenny. "Les cellules de Langerhans." médecine/sciences 22, no. 2 (2006): 144–48. http://dx.doi.org/10.1051/medsci/2006222144.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ghanem, Ismat, Antoine Checrallah, Khalil Kharrat, and Fernand Dagher. "Histiocytose à cellules de Langerhans." EMC - Appareil locomoteur 1, no. 1 (2006): 1–14. http://dx.doi.org/10.1016/s0246-0521(01)00098-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Bieber, T. "Cellules de Langerhans et allergie." Revue Française d'Allergologie et d'Immunologie Clinique 34, no. 6 (1994): 481–84. http://dx.doi.org/10.1016/s0335-7457(05)80392-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ghanem, Ismat, Antoine Checrallah, Khalil Kharrat, and Dagher Fernand. "Histiocytose à cellules de Langerhans." EMC - Appareil locomoteur 15, no. 3 (2001): 1–14. https://doi.org/10.1016/s0246-0521(19)30320-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lacronique, Jacques, François Basset, and Allan Hance. "Granulomatose pulmonaire à cellules de Langerhans." EMC - Pneumologie 6, no. 3 (1995): 1. https://doi.org/10.1016/s1155-195x(20)30120-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

de Menthon, Mathilde, Véronique Meignin, Alfred Mahr, and Abdellatif Tazi. "Histiocytose à cellules de Langerhans de l’adulte." La Presse Médicale 46, no. 1 (2017): 55–69. http://dx.doi.org/10.1016/j.lpm.2016.09.015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Bieber, Th. "Les cellules de Langerhans : Utiles ou néfastes?" Revue Française d'Allergologie et d'Immunologie Clinique 36, no. 5 (1996): 445–52. http://dx.doi.org/10.1016/s0335-7457(96)80001-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bronfen, C., B. Geffard, O. Minckès, P. Boutard, and C. Jeanne Pasquier. "Histiocytoses à cellules de Langerhans de découverte « orthopédique »." Revue de Chirurgie Orthopédique et Réparatrice de l'Appareil Moteur 94, no. 4 (2008): 63. http://dx.doi.org/10.1016/j.rco.2008.03.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Emile, J. F., M. Peuchmaur, and N. Brousse. "Contrôle des cellules de Langerhans par le GM-CSF." médecine/sciences 10, no. 2 (1994): 171. http://dx.doi.org/10.4267/10608/2583.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lega, J. C., V. Cottin, A. Schuller, R. Lazor, D. Jullien, and J. F. Cordier. "Présentation pulmonaire inhabituelle d’une histiocytose à cellules de Langerhans systémique." La Revue de Médecine Interne 29, no. 8 (2008): 669–72. http://dx.doi.org/10.1016/j.revmed.2007.12.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Reach, G., S. Darquy, and V. Poitout. "Utilisation des cellules des îlots de Langerhans en thérapie cellulaire." Transfusion Clinique et Biologique 5, no. 1 (1998): 88–96. http://dx.doi.org/10.1016/s1246-7820(98)80114-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Séguier, S., F. Geissmann, and N. Brousse. "Les cellules de Langerhans au cours des gingivites et des parodontites." médecine/sciences 14, no. 11 (1998): 1222. http://dx.doi.org/10.4267/10608/941.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Valladeau, J., and S. Saeland. "La Langerine et les granules de Birbeck des cellules de Langerhans." médecine/sciences 16, no. 8-9 (2000): 979. http://dx.doi.org/10.4267/10608/1769.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Papoz, Anastasia, Flora Clément, Camille Laporte, Emily Tubbs, Xavier Gidrol, and Amandine Pitaval. "Les Langerhanoïdes, des organoïdes d’îlots pancréatiques." médecine/sciences 38, no. 1 (2022): 52–58. http://dx.doi.org/10.1051/medsci/2021244.

Full text

Abstract:

Les îlots de Langerhans isolés de donneurs en état de mort encéphalique constituent actuellement la seule source de cellules pour la transplantation de patients atteints de diabète de type 1. Cette approche thérapeutique reste cependant compromise par la rareté des donneurs et par certains aspects techniques. L’utilisation de sources alternatives de cellules productrices d’insuline est donc un enjeu tant thérapeutique que pour la recherche pharmacologique. Plusieurs équipes dans le monde, dont la nôtre, développent des modèles de culture cellulaire en 3D, les Langerhanoïdes, qui sont physiolog

APA, Harvard, Vancouver, ISO, and other styles

15

Ximenes Filho, João Aragão, Francisco Valdeci Ferreira, Francisco Dário Rocha Filho, Domingos Hiroshi Tsuji, and Luiz Ubirajara Sennes. "Células de Langerhans no epitélio da prega vocal humana: estudo imunoistoquímico." Revista Brasileira de Otorrinolaringologia 70, no. 5 (2004): 584–88. http://dx.doi.org/10.1590/s0034-72992004000500002.

Full text

Abstract:

Células de Langerhans (CL) são um tipo de células dendríticas que têm funções que envolvem apresentação de antígeno e a estimulação de resposta T dependente. Elas representam aproximadamente 4% das células do epitélio laríngeo. OBJETIVO: Identificar a presença de CL no epitélio das pregas vocais, comparar suas subpopulações, bem com comparar a capacidade de quatro marcadores imunoistoquímicos. FORMA DE ESTUDO: Experimental. CASUÍSTICA E MÉTODO: Seis cadáveres, 3 homens e 3 mulheres foram estudados. Foram analisadas amostras de pele e das pregas vocais coradas e imunomarcadas para vimentina, pr

APA, Harvard, Vancouver, ISO, and other styles

16

Grondin, K., R. Caissie, and V. Bernier. "Histiocytose à cellules de Langerhans : histoire d’un cas à présentation multifocale et multisystémique." Annales de Pathologie 25, no. 2 (2005): 182. http://dx.doi.org/10.1016/s0242-6498(05)86193-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Chasset, F., L. Deschamps, E. Marinho, B. Crickx, and V. Descamps. "Diminution du nombre de cellules de Langerhans intra-épidermiques au cours du glucagonome." Annales de Dermatologie et de Vénéréologie 139, no. 12 (2012): B244—B245. http://dx.doi.org/10.1016/j.annder.2012.10.435.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Deveza, E., F. Vitte, A. S. Dupond, et al. "Cellules de Langerhans et histiocytofibrome, étude immuno-histochimique à propos de 53 cas." Annales de Dermatologie et de Vénéréologie 140, no. 12 (2013): S468—S469. http://dx.doi.org/10.1016/j.annder.2013.09.245.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Agüero, M. Gomez de, C. Macari, M. Vocanson, et al. "Cellules de Langerhans et contrôle de la réactivité cutanée aux allergènes de contact." Annales de Dermatologie et de Vénéréologie 140, no. 12 (2013): S625—S626. http://dx.doi.org/10.1016/j.annder.2013.09.649.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Ben Brahim, E., W. Koubâa, M. Zghal, et al. "Rôle des cellules de Langerhans dans la progression du mélanome au cours du xeroderma pigmentosum." Annales de Dermatologie et de Vénéréologie 138, no. 12 (2011): A286. http://dx.doi.org/10.1016/j.annder.2011.10.381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Valladeau, J., C. Caux, S. Lebecque, and S. Saeland. "Langerin : une nouvelle lectine spécifique des cellules de Langerhans induit la formation de granules de Birbeck." Pathologie Biologie 49, no. 6 (2001): 454–55. http://dx.doi.org/10.1016/s0369-8114(01)00163-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Zakkouri, F. A., J. Klastersky, J. Alexiou, et al. "Histiocytose agressive à cellules de Langerhans 20 ans après un cancer du sein : à propos d’un cas." Journal Africain du Cancer / African Journal of Cancer 5, no. 4 (2013): 220–23. http://dx.doi.org/10.1007/s12558-013-0276-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Mande, Purvi, Keyon Taravati, Michael Rosenblum, and Ann Marshak Rothstein. "Taking a ‘Toll’ on Skin: A novel TLR9-deficient Model of Cutaneous Lupus." Journal of Immunology 198, no. 1_Supplement (2017): 207.2. http://dx.doi.org/10.4049/jimmunol.198.supp.207.2.

Full text

Abstract:

Abstract Endosomal Toll-like receptors (TLRs), TLR7 and TLR9 have been implicated in the pathogenesis of systemic lupus erythematosus (SLE). However, their role in cutaneous lupus (CL) is not well established, in part due to lack of appropriate mouse models for CL. We developed a novel murine model of CL that depends on T cell recognition of an ovalbumin (OVA) peptide on MHC class II+ cells and closely mimics human CL. These mice develop epidermal hyperplasia associated with mononuclear interface dermatitis and IgG deposition at the dermal-epidermal border within 4 weeks of administration of “

APA, Harvard, Vancouver, ISO, and other styles

24

Devoize, Laurent, Martine Baudet-Pommel, Cédric Huard, Hélène Gouby, and Jean-Michel Mondié. "Histiocytose à cellules de Langerhans : suivi à long terme de deux cas à localisation faciale traités par chirurgie exclusive." Médecine Buccale Chirurgie Buccale 11, no. 3 (2005): 159–73. http://dx.doi.org/10.1051/mbcb/2005013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Schmitt, D. "Cellules dendritiques et allergie cutanée : la cellule de Langerhans dans l'allergie de contact et les tests prédictifs in vitro." Revue Française d'Allergologie et d'Immunologie Clinique 37, no. 3 (1997): 243–52. http://dx.doi.org/10.1016/s0335-7457(97)80156-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Avetisov, S. E., Z. V. Surnina, L. M. Agaeva, and T. A. Mamedov. "Diagnostic capabilities of corneal confocal microscopy in monitoring local conservative therapy to prevent early recurrence of chronic anterior uveitis associated with spondyloarthritis." Modern technologies in ophtalmology 60, no. 2 (2025): 229–30. https://doi.org/10.25276/2312-4911-2025-2-229-230.

Full text

Abstract:

Relevance Associated anterior uveitis (PU) is characterized by a high relapse rate - from 47.5 to 90.9%. Exacerbations last from 5-7 weeks to 3 months, with a frequency of 0.6-3.3 times per year. Relapses can be accompanied by a more severe course, involvement of the posterior segment of the eye, complications and a significant decrease in visual acuity. Langerhans cells (LC) - atypical macrophages that activate innate and adaptive immunity in anterior uveitis - play a key role in the inflammatory response. In a healthy cornea, Langerhans cells, represented by resident dendritic cells, are fou

APA, Harvard, Vancouver, ISO, and other styles

27

Dioszeghy, V., O. Langlois, V. Dhelft, et al. "Profil d’activation tolérogène des cellules de Langerhans lors de la prise en charge d’allergène après administration épicutanée sur peau intacte." Revue Française d'Allergologie 57, no. 3 (2017): 278–79. http://dx.doi.org/10.1016/j.reval.2017.02.207.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Nuha S. Al-Bayatii, Fatima Sh. Al-Naserii, and Jaladet M.S. Jubrael. "Determination of Immunoglobulin's levels in cutaneous Leishmainasis patients." Tikrit Journal of Pure Science 20, no. 2 (2023): 40–43. http://dx.doi.org/10.25130/tjps.v20i2.1156.

Full text

Abstract:

Human leishmaniasis is distributed worldwide, butmainly in the tropics and subtropics, with a prevalenceof 12 million cases and an approximate incidence of 0.5million cases of VL (visceral leishmaniasis) and 1.5 million cases of cutaneousleishmaniasis (CL) Leishmaniaspecies are intra‐cellularparasites invading monocytes, macrophages, and langerhans celland begin the differentiation process into amastigotes, the parasite form which persists in the host. Theirinfection in man induces both humoral andcellular immune responses, but the balanceof their expression varies with the type of the disease

APA, Harvard, Vancouver, ISO, and other styles

29

Yibchok-Anun, Sirintorn, Henrique Cheng, Patricia A. Heine, and Walter H. Hsu. "Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas." American Journal of Physiology-Endocrinology and Metabolism 277, no. 1 (1999): E56—E62. http://dx.doi.org/10.1152/ajpendo.1999.277.1.e56.

Full text

Abstract:

We characterized the receptors that mediate arginine vasopressin (AVP)- and oxytocin (OT)-induced glucagon release by use of a number of antagonists in the perfused rat pancreas and the fluorescence imaging of the receptors. AVP and OT (3 pM-3 nM) increased glucagon release in a concentration-dependent manner. The antagonist with potent V1b receptor-blocking activity, CL-4–84 (10 nM), abolished AVP (30 pM)-induced glucagon release but did not alter OT (30 pM)-induced glucagon release. d(CH2)5[Tyr(Me)2]AVP (10 nM), a V1a receptor antagonist, and L-366,948 (10 nM), a highly specific OT-receptor

APA, Harvard, Vancouver, ISO, and other styles

30

C.P. "La migration des cellules de Langerhans de l'épiderme vers les ganglions lymphatiques est augmentée chez les souris knock-out pour le gène de l'IL-10." Revue Française d'Allergologie et d'Immunologie Clinique 40, no. 4 (2000): 510. http://dx.doi.org/10.1016/s0335-7457(00)80125-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

C.P. "Activation in vivo des cellules de Langerhans et des lymphocytes T intraépithéliaux d'aspect dendritique dans la réaction cutanée d'hypersensibilité retardée de contact, chez la souris." Revue Française d'Allergologie et d'Immunologie Clinique 40, no. 8 (2000): 819. http://dx.doi.org/10.1016/s0335-7457(00)80172-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Ma, Zuheng, Anneli Björklund, and Md Shahidul Islam. "A TRPM4 Inhibitor 9-Phenanthrol Inhibits Glucose- and Glucagon-Like Peptide 1-Induced Insulin Secretion from Rat Islets of Langerhans." Journal of Diabetes Research 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/5131785.

Full text

Abstract:

Pancreatic β-cells express several ion channels of the transient receptor potential family, which play important roles in mediating the stimulus-secretion coupling. One of these channels, the TRPM4 is a Ca2+-activated monovalent cation channel. This channel is inhibited by 9-phenanthrol, which also inhibits the TMEM16a Cl− channel, and activates the Ca2+-activated K+ channel, Kca3.1. The net effects of ion-channel modulation by 9-phenantherol on the insulin secretion remain unclear. We tested the effects of 9-phenanthrol on glucose- and GLP-1-induced insulin secretion from isolated rat islets

APA, Harvard, Vancouver, ISO, and other styles

33

C.P. "Les irradiations locales par les rayons ultraviolets B inhibent l'induction des sensiblisations retardées aux antigènes de contact en induisant la libération de TNF-α par les mastocytes : rôle des mastocytes et des cellules de Langerhans dans la susceptibilité aux UVB". Revue Française d'Allergologie et d'Immunologie Clinique 40, № 8 (2000): 821. http://dx.doi.org/10.1016/s0335-7457(00)80178-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

M.Hajji, FZ L.aamrani and L. Jroundi. "A RARE LOCALISATION OF HYSTIOCYTOSIS." October 15, 2019. https://doi.org/10.5281/zenodo.3553516.

Full text

Abstract:

Lhistiocytose Langerhansienne, ou histiocytose X est une maladie systemique liee a une accumulation dans les tissus de cellules de Langerhans, le plus souvent organisees en granulomes. Sa localisation thyro?dienne est relativement rare, et pose des difficultes diagnostiques et therapeutiques particulieres. Son diagnostic necessite souvent le recours a une confrontation clinique, radiologique et anatomopathologique

APA, Harvard, Vancouver, ISO, and other styles

35

Sahel, Houria, Billel Merrouche, Souad Bellaifa, et al. "Une maladie d’Erdheim-Chester associée à une histiocytose à cellules de Langerhans : un cas d’une forme mixte." La Revue de Médecine Interne, April 2025. https://doi.org/10.1016/j.revmed.2025.02.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

SANTOS, LUCIANO CINCURÁ SILVA, JEAN DOS SANTOS NUNES, IVANA LÚCIA OLIVEIRA NASCIMENTO, and ANTONIO IRINEU TRINDADE NETO. "Célula de Langerhans: revisão de literatura e seu envolvimento em lesões orais." Revista Uningá 27, no. 1 (2011). https://doi.org/10.46311/2318-0579.27.euj935.

Full text

Abstract:

Sabe-se que toda agressão tecidual gera uma resposta inflamatória. É nesse contexto dereação imuno-inflamatória desencadeada pelo desenvolvimento neoplásico, que ascélulas dendríticas surgem como possíveis “carreadoras” da resposta adquirida, podendoassim contribuir com a etiopatogenia de algumas lesões orais. As Células de Langerhans(CL), oriundas da medula óssea, são células apresentadoras profissionais de antígenos,responsáveis pela apresentação destes aos linfócitos T. A produção de citocinasresultante da apresentação antigênica aos linfócitos parecem influenciar o processo decrescimento d

APA, Harvard, Vancouver, ISO, and other styles

37

Atnafu, Abay, Zewditu Chanyalew, Sofia Yimam, et al. "Histopathological Patterns of Cutaneous and Mucocutaneous Leishmaniasis Due to L. aethiopica." Dermatology Research and Practice 2024, no. 1 (2024). http://dx.doi.org/10.1155/drp/5267606.

Full text

Abstract:

Background: Cutaneous leishmaniasis (CL) is an endemic disease in Ethiopia, mainly caused by L. aethiopica. Limited reports are available related to histopathological features of the skin lesion caused by L. aethiopica. This study aimed to analyze the histopathological features of CL due to L. aethiopica.Materials and Methods: A similar cohort polymerase chain reaction (PCR) confirmed CL patients from a previous own study, who were prospectively enrolled from All Africa Leprosy, Tuberculosis and Rehabilitation Training (ALERT) Hospital Addis Ababa, Kela Health Center in Gurage Zone, Siliti Hea

APA, Harvard, Vancouver, ISO, and other styles

38

AKA, Pancrace, and David Kra Yao KOSSONOU. "L'épistémologie du hasard de Jacques Monod : une clé de compréhension du cancer ?" May 9, 2025. https://doi.org/10.5281/zenodo.15376457.

Full text

Abstract:

L’épistémologie du hasard de Jacques Monod admet que toute nouveauté, en l’occurrence la prolifération anormale et désordonnée des cellules, dans l’organisation du vivant résulte des mutations génétiques qui sont l’expression du hasard essentiel. Dans cette logique, elle apparaît comme une clé de compréhension du cancer, puisqu’elle s’harmonise fort bien avec la théorie des mutations somatiques selon laquelle le développement de cette pathologie est dû aux

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!